Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Witte

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Journal of Insurance Medicine (New York, N.Y.)|December 5, 1991
Hemochromatosis 1991. What will increased clinical screening mean for medical directors?D L Witte, B R Kay
Clinical Chemistry|May 1, 1997
Panel discussion: how to monitor and minimize variation and mistakesD L Witte, M L Astion
Clinical Chemistry|April 1, 1994
Serum iron: would analytical improvement enhance patient outcome?J H Eckfeldt, D L Witte
Clinical Chemistry|October 1, 1977
Presence of creatine kinase BB isoenzyme in some patients with prostatic carcinomaR D Feld, D L Witte
JAMA|December 14, 1979
Platelet and leukocyte counts in pregnancyR M Pitkin, D L Witte
Journal of Insurance Medicine (New York, N.Y.)|February 3, 1992
The impact of cancer biology, lead time bias, and length bias in the debate about cancer screening testsB R Kay, D L Witte
Archives of Pathology & Laboratory Medicine|August 24, 1999
Frequency of unacceptable results in point-of-care testingD L Witte, S A VanNess
The Journal of Pediatrics|June 11, 1976
Letter: Is Dextrostix adequate to assess neonatal hypoglycemia?D A Barrett, D L Witte, L Brown
Clinical Chemistry|May 1, 1976
Kinetic determination of serum lipase activity with the Abbott ABA-100R D Feld, D L Witte, D A Barrett
Clinical Chemistry|October 1, 1978
Effects of bilirubin on detection of hydrogen peroxide by use of peroxidaseD L Witte, L F Brown, R D Feld
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Journal of Insurance Medicine (New York, N.Y.)|December 5, 1991
Hemochromatosis 1991. What will increased clinical screening mean for medical directors?D L Witte, B R Kay
Clinical Chemistry|May 1, 1997
Panel discussion: how to monitor and minimize variation and mistakesD L Witte, M L Astion
Clinical Chemistry|April 1, 1994
Serum iron: would analytical improvement enhance patient outcome?J H Eckfeldt, D L Witte
Clinical Chemistry|October 1, 1977
Presence of creatine kinase BB isoenzyme in some patients with prostatic carcinomaR D Feld, D L Witte
JAMA|December 14, 1979
Platelet and leukocyte counts in pregnancyR M Pitkin, D L Witte
Journal of Insurance Medicine (New York, N.Y.)|February 3, 1992
The impact of cancer biology, lead time bias, and length bias in the debate about cancer screening testsB R Kay, D L Witte
Archives of Pathology & Laboratory Medicine|August 24, 1999
Frequency of unacceptable results in point-of-care testingD L Witte, S A VanNess
The Journal of Pediatrics|June 11, 1976
Letter: Is Dextrostix adequate to assess neonatal hypoglycemia?D A Barrett, D L Witte, L Brown
Clinical Chemistry|May 1, 1976
Kinetic determination of serum lipase activity with the Abbott ABA-100R D Feld, D L Witte, D A Barrett
Clinical Chemistry|October 1, 1978
Effects of bilirubin on detection of hydrogen peroxide by use of peroxidaseD L Witte, L F Brown, R D Feld
Pageof 5